Literature DB >> 27832562

Accuracy of dispersing tramadol capsules for oral administration in young children.

M Kluger1, S Penrose2, A R Bjorksten3, G Chalkiadis4.   

Abstract

Tramadol is used in children aged <12 years for analgesia, particularly for those at risk of obstructive sleep apnoea undergoing adenotonsillectomy. The Australian Therapeutic Goods Administration have strongly recommended that oral tramadol drops (100 mg/ml) not be used in children <12 years because of the risk of inadvertent overdose. The total mass of drug in a 10 ml bottle is 1000 mg. The only alternative preparation available is a 50 mg capsule that requires dispersion of a capsule's contents should smaller doses be required. The accuracy of this preparation has not been assessed. Twenty surgical ward nurses were asked to prepare a 15 mg dose of tramadol from a 50 mg capsule. The dose was within ±5% of 15 mg in 13 cases (65%) and within ±10% in 19 cases (95%) (range 13.9-17.1 mg). Despite the dose variability of this method of preparing tramadol, we consider it sufficiently accurate for clinical use. We also consider it safe, as even at the highest dose prepared, the variability would be unlikely to contribute to clinically significant side-effects or toxicity. Moreover, the maximal dose that could be administered is limited to the size of the capsule (50 mg).

Entities:  

Keywords:  analgesia, capsule, child, human, pain management, tramadol

Mesh:

Substances:

Year:  2016        PMID: 27832562     DOI: 10.1177/0310057X1604400613

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  2 in total

Review 1.  The use of oral opioids to control children's pain in the post-codeine era.

Authors:  Michael J Rieder; Geert 't Jong
Journal:  Paediatr Child Health       Date:  2021-03-16       Impact factor: 2.253

Review 2.  Les opioïdes par voie orale en remplacement de la codéine pour contrôler la douleur chez les enfants.

Authors:  Michael J Rieder; Geert 't Jong
Journal:  Paediatr Child Health       Date:  2021-03-16       Impact factor: 2.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.